BMS-813160 50 mg | 99.66%
TargetMol
BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular.
More Information Supplier PageBMS-813160
Search Results
ML311 1 mg | 99.75%
TargetMol
ML311
SCH 58261 10 mg | 99.75%
TargetMol
SCH 58261 is a potent and selective A2a adenosine receptor antagonist.The Ki =2.3 nM for rat A2a and 2 nM is for bovine A2a.
More Information Supplier PageSCH 58261
SCH 58261 2 mg | 99.75%
TargetMol
SCH 58261 is a potent and selective A2a adenosine receptor antagonist.The Ki =2.3 nM for rat A2a and 2 nM is for bovine A2a.
More Information Supplier PageSCH 58261
ML311 100 mg | 99.75%
TargetMol
ML311
ML311 50 mg | 99.75%
TargetMol
ML311
ML311 25 mg | 99.75%
TargetMol
ML311
ML311 10 mg | 99.75%
TargetMol
ML311
ML311 5 mg | 99.75%
TargetMol
ML311
ML311 2 mg | 99.75%
TargetMol
ML311